Robust response to virus variants expected in former COVID patients and the vaccinated
By
Alicia Lasek
Mar 31, 2021
Blood samples from recovered COVID-19 patients show that they and their vaccinated peers should be able to fend off the virus and its variants in future encounters, NIH researchers say.
Fauci: ‘Pan-viral’ vaccine may be needed to tackle tenacious COVID-19 long-term
By
Alicia Lasek
Feb 16, 2021
The virus that causes COVID-19 likely is here to stay, and its success in humans means that stronger defense measures will be needed, say Anthony Fauci, M.D., and colleagues from the National Institute...
U.S. asthma guidelines updated for first time since 2007
By
Alicia Lasek
Dec 04, 2020
The update includes 19 recommendations in six key areas of asthma diagnosis, management and treatment. Several new features aim to help clinicians put the recommendations into practice, and the stepwise...
Funding for Alzheimer’s research in question
By
McKnight's Staff
Apr 05, 2012
The $80 million President Obama designated to Alzheimer’s research could have more strings attached to it than previously thought, a key senator has said.
Feds identify promising and ‘urgently needed’ COVID antiviral drug
By
Alicia Lasek
Jun 04, 2021
The experimental drug TEMPOL has shown promise in early studies, halting the activity of a viral enzyme and limiting the severity of SARS-CoV-2 infections.
Remdesivir effective against COVID-19, researchers conclude
By
Alicia Lasek
Oct 13, 2020
Intravenous remdesivir shortens recovery time and reduces mortality in hospitalized patients when compared to placebo, according to final trial data from NIAID. No other antiviral has yet been confirmed...